-
1
-
-
79651471340
-
Histone methyltransferase G9a contributes to H3K27 methylation in vivo
-
Wu, H. et al. Histone methyltransferase G9a contributes to H3K27 methylation in vivo. Cell. Res. 21, 365-367 (2011).
-
(2011)
Cell. Res
, vol.21
, pp. 365-367
-
-
Wu, H.1
-
2
-
-
0037099413
-
G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis
-
Tachibana, M. et al. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev. 16, 1779-1791 (2002).
-
(2002)
Genes Dev
, vol.16
, pp. 1779-1791
-
-
Tachibana, M.1
-
3
-
-
80051543424
-
Enhanced expression of EHMT2 is involved in the proliferation of cancer cells through negative regulation of SIAH1
-
Cho, H. S. et al. Enhanced expression of EHMT2 is involved in the proliferation of cancer cells through negative regulation of SIAH1. Neoplasia (New York, NY) 13, 676-684 (2011).
-
(2011)
Neoplasia (New York, NY)
, vol.13
, pp. 676-684
-
-
Cho, H.S.1
-
4
-
-
84859731270
-
G9a interacts with snail and is critical for snail-mediated E-cadherin repression in human breast cancer
-
Dong, C. et al. G9a interacts with snail and is critical for snail-mediated E-cadherin repression in human breast cancer. J. Clin. Invest. 122, 1469-1486 (2012).
-
(2012)
J. Clin. Invest
, vol.122
, pp. 1469-1486
-
-
Dong, C.1
-
5
-
-
84923311761
-
Down-regulation of G9a triggers DNA damage response and inhibits colorectal cancer cells proliferation
-
Zhang, J. et al. Down-regulation of G9a triggers DNA damage response and inhibits colorectal cancer cells proliferation. Oncotarget 6, 2917-2927 (2015).
-
(2015)
Oncotarget
, vol.6
, pp. 2917-2927
-
-
Zhang, J.1
-
6
-
-
84989846311
-
Histone lysine methyltransferases as anti-cancer targets for drug discovery
-
Liu, Q. & Wang, M. W. Histone lysine methyltransferases as anti-cancer targets for drug discovery. Acta Pharmacol. Sin. 37, 1273-1280 (2016).
-
(2016)
Acta Pharmacol. Sin
, vol.37
, pp. 1273-1280
-
-
Liu, Q.1
Wang, M.W.2
-
7
-
-
84864319642
-
Mammalian iron metabolism and its control by iron regulatory proteins
-
Anderson, C. P., Shen, M., Eisenstein, R. S. & Leibold, E. A. Mammalian iron metabolism and its control by iron regulatory proteins. Biochim. Biophys. Acta 1823, 1468-1483 (2012).
-
(2012)
Biochim. Biophys. Acta
, vol.1823
, pp. 1468-1823
-
-
Anderson, C.P.1
Shen, M.2
Eisenstein, R.S.3
Leibold, E.A.4
-
8
-
-
50949102412
-
Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network
-
Muckenthaler, M. U., Galy, B. & Hentze, M. W. Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network. Annu. Rev. Nutr. 28, 197-213 (2008).
-
(2008)
Annu. Rev. Nutr
, vol.28
, pp. 197-213
-
-
Muckenthaler, M.U.1
Galy, B.2
Hentze, M.W.3
-
9
-
-
84876854791
-
Iron and cancer: More ore to be mined
-
Torti, S. V. & Torti, F. M. Iron and cancer: more ore to be mined. Nat. Rev. Cancer 13, 342-355 (2013).
-
(2013)
Nat. Rev. Cancer
, vol.13
, pp. 342-355
-
-
Torti, S.V.1
Torti, F.M.2
-
10
-
-
84926350246
-
Cellular iron homeostasis and therapeutic implications of iron chelators in cancer
-
Raza, M., Chakraborty, S., Choudhury, M., Ghosh, P. C. & Nag, A. Cellular iron homeostasis and therapeutic implications of iron chelators in cancer. Curr. Pharm. Biotechnol. 15, 1125-1140 (2014).
-
(2014)
Curr. Pharm. Biotechnol
, vol.15
, pp. 1125-1140
-
-
Raza, M.1
Chakraborty, S.2
Choudhury, M.3
Ghosh, P.C.4
Nag, A.5
-
11
-
-
84983268608
-
EGFR regulates iron homeostasis to promote cancer growth through redistribution of transferrin receptor 1
-
Wang, B. et al. EGFR regulates iron homeostasis to promote cancer growth through redistribution of transferrin receptor 1. Cancer Lett. 381, 331-340 (2016).
-
(2016)
Cancer Lett
, vol.381
, pp. 331-340
-
-
Wang, B.1
-
12
-
-
77955607931
-
Ferroportin and iron regulation in breast cancer progression and prognosis
-
Pinnix, Z. K. et al. Ferroportin and iron regulation in breast cancer progression and prognosis. Sci. Transl. Med. 2, 43ra56 (2010).
-
(2010)
Sci. Transl. Med
, vol.2
, pp. 43ra56
-
-
Pinnix, Z.K.1
-
13
-
-
77954998621
-
And hephaestin overexpression attenuate iron-induced oxidative stress in MES23.5 dopaminergic cells
-
Song, N., Wang, J., Jiang, H. & Xie, J. Ferroportin1 and hephaestin overexpression attenuate iron-induced oxidative stress in MES23.5 dopaminergic cells. J. Cell. Biochem. 110, 1063-1072 (2010).
-
(2010)
J. Cell. Biochem
, vol.110
, pp. 1063-1072
-
-
Song, N.1
Wang, J.2
Jiang, H.3
Ferroportinl, X.J.4
-
14
-
-
84929486072
-
Hephaestin and ceruloplasmin play distinct but interrelated roles in iron homeostasis in mouse brain
-
Jiang, R. et al. Hephaestin and ceruloplasmin play distinct but interrelated roles in iron homeostasis in mouse brain. J. Nutr. 145, 1003-1009 (2015).
-
(2015)
J. Nutr
, vol.145
, pp. 1003-1009
-
-
Jiang, R.1
-
15
-
-
72649090521
-
Ferroportin 1 but not hephaestin contributes to iron accumulation in a cell model of Parkinson's disease
-
Song, N., Wang, J., Jiang, H. & Xie, J. Ferroportin 1 but not hephaestin contributes to iron accumulation in a cell model of Parkinson's disease. Free Radic. Biol. Med. 48, 332-341 (2010).
-
(2010)
Free Radic. Biol. Med
, vol.48
, pp. 332-341
-
-
Song, N.1
Wang, J.2
Jiang, H.3
Xie, J.4
-
16
-
-
84920577188
-
Ceruloplasmin, hephaestin and zyklopen: The three multicopper oxidases important for human iron metabolism
-
Wierzbicka, D. & Gromadzka, G. Ceruloplasmin, hephaestin and zyklopen: the three multicopper oxidases important for human iron metabolism. Postepy. Hig. Med. Dosw. 68, 912-924 (2014).
-
(2014)
Postepy. Hig. Med. Dosw
, vol.68
, pp. 912-924
-
-
Wierzbicka, D.1
Gromadzka, G.2
-
17
-
-
15044358801
-
Hephaestin-a ferroxidase of cellular iron export
-
Petrak, J. & Vyoral, D. Hephaestin-a ferroxidase of cellular iron export. Int. J. Biochem. Cell. Biol. 37, 1173-1178 (2005).
-
(2005)
Int. J. Biochem. Cell. Biol
, vol.37
, pp. 1173-1178
-
-
Petrak, J.1
Vyoral, D.2
-
18
-
-
84902437063
-
The multicopper ferroxidase hephaestin enhances intestinal iron absorption in mice
-
Fuqua, B. K. et al. The multicopper ferroxidase hephaestin enhances intestinal iron absorption in mice. PLoS ONE 9, e98792 (2014).
-
(2014)
PLoS ONE
, vol.9
, pp. e98792
-
-
Fuqua, B.K.1
-
19
-
-
0036176282
-
Cellular location of proteins related to iron absorption and transport
-
Simovich, M. J. et al. Cellular location of proteins related to iron absorption and transport. Am. J. Hematol. 69, 164-170 (2002).
-
(2002)
Am. J. Hematol
, vol.69
, pp. 164-170
-
-
Simovich, M.J.1
-
20
-
-
33646386896
-
Decreased hephaestin activity in the intestine of copper-deficient mice causes systemic iron deficiency
-
Chen, H. et al. Decreased hephaestin activity in the intestine of copper-deficient mice causes systemic iron deficiency. J. Nutr. 136, 1236-1241 (2006).
-
(2006)
J. Nutr
, vol.136
, pp. 1236-1241
-
-
Chen, H.1
-
21
-
-
84879910312
-
Intestinal iron homeostasis and colon tumorigenesis
-
Xue, X. & Shah, Y. M. Intestinal iron homeostasis and colon tumorigenesis. Nutrients 5, 2333-2351 (2013).
-
(2013)
Nutrients
, vol.5
, pp. 2333-2351
-
-
Xue, X.1
Shah, Y.M.2
-
22
-
-
84952893202
-
Recent advances in cancer treatment by iron chelators
-
Corce, V., Gouin, S. G., Renaud, S., Gaboriau, F. & Deniaud, D. Recent advances in cancer treatment by iron chelators. Bioorg. Med. Chem. Lett. 26, 251-256 (2016).
-
(2016)
Bioorg. Med. Chem. Lett
, vol.26
, pp. 251-256
-
-
Corce, V.1
Gouin, S.G.2
Renaud, S.3
Gaboriau, F.4
Deniaud, D.5
-
23
-
-
17144407567
-
CDX2-regulated expression of iron transport protein hephaestin in intestinal and colonic epithelium
-
Hinoi, T. et al. CDX2-regulated expression of iron transport protein hephaestin in intestinal and colonic epithelium. Gastroenterology. 128, 946-961 (2005).
-
(2005)
Gastroenterology
, vol.128
, pp. 946-961
-
-
Hinoi, T.1
-
24
-
-
84855840322
-
Mechanisms of Yin Yang 1 in oncogenesis: The importance of indirect effects
-
Atchison, M., Basu, A., Zaprazna, K. & Papasani, M. Mechanisms of Yin Yang 1 in oncogenesis: the importance of indirect effects. Crit. Rev. Oncog. 16, 143-161 (2011).
-
(2011)
Crit. Rev. Oncog
, vol.16
, pp. 143-161
-
-
Atchison, M.1
Basu, A.2
Zaprazna, K.3
Papasani, M.4
-
25
-
-
77956915397
-
Histone modifiers, YY1 and p300, regulate the expression of cartilage-specific gene, chondromodulin-I, in mesenchymal stem cells
-
Aoyama, T. et al. Histone modifiers, YY1 and p300, regulate the expression of cartilage-specific gene, chondromodulin-I, in mesenchymal stem cells. J. Biol. Chem. 285, 29842-29850 (2010).
-
(2010)
J. Biol. Chem
, vol.285
, pp. 29842-29850
-
-
Aoyama, T.1
-
26
-
-
0037069940
-
YY1 and NF-Y binding sites regulate the transcriptional activity of the dek and dek-can promoter
-
Sitwala, K. V., Adams, K. & Markovitz, D. M. YY1 and NF-Y binding sites regulate the transcriptional activity of the dek and dek-can promoter. Oncogene 21, 8862-8870 (2002).
-
(2002)
Oncogene
, vol.21
, pp. 8862-8870
-
-
Sitwala, K.V.1
Adams, K.2
Markovitz, D.M.3
-
27
-
-
84930507863
-
H3K9 methyltransferase G9a negatively regulates UHRF1 transcription during leukemia cell differentiation
-
Kim, K. B. et al. H3K9 methyltransferase G9a negatively regulates UHRF1 transcription during leukemia cell differentiation. Nucleic Acids Res. 43, 3509-3523 (2015).
-
(2015)
Nucleic Acids Res
, vol.43
, pp. 3509-3523
-
-
Kim, K.B.1
-
28
-
-
84866343568
-
Negative regulation of JAK2 by H3K9 methyltransferase G9a in leukemia
-
Son, H. J., Kim, J. Y., Hahn, Y. & Seo, S. B. Negative regulation of JAK2 by H3K9 methyltransferase G9a in leukemia. Mol. Cell. Biol. 32, 3681-3694 (2012).
-
(2012)
Mol. Cell. Biol
, vol.32
, pp. 3681-3694
-
-
Son, H.J.1
Kim, J.Y.2
Hahn, Y.3
Seo, S.B.4
-
29
-
-
67349137868
-
Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents
-
Richardson, D. R., Kalinowski, D. S., Lau, S., Jansson, P. J. & Lovejoy, D. B. Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents. Biochim. Biophys. Acta 1790, 702-717 (2009).
-
(2009)
Biochim. Biophys. Acta
, vol.1790
, pp. 702-717
-
-
Richardson, D.R.1
Kalinowski, D.S.2
Lau, S.3
Jansson, P.J.4
Lovejoy, D.B.5
-
30
-
-
84949775253
-
Association studies of HFE C282Y and H63D variants with oral cancer risk and iron homeostasis among whites and blacks
-
Jones, N. R. et al. Association studies of HFE C282Y and H63D variants with oral cancer risk and iron homeostasis among whites and blacks. Cancers 7, 2386-2396 (2015).
-
(2015)
Cancers
, vol.7
, pp. 2386-2396
-
-
Jones, N.R.1
-
31
-
-
84926372869
-
Macrophage iron homeostasis and polarization in the context of cancer
-
Jung, M., Mertens, C. & Brune, B. Macrophage iron homeostasis and polarization in the context of cancer. Immunobiology. 220, 295-304 (2015).
-
(2015)
Immunobiology
, vol.220
, pp. 295-304
-
-
Jung, M.1
Mertens, C.2
Brune, B.3
-
32
-
-
0038324398
-
The role of iron chelation in cancer therapy
-
Buss, J. L., Torti, F. M. & Torti, S. V. The role of iron chelation in cancer therapy. Curr. Med. Chem. 10, 1021-1034 (2003).
-
(2003)
Curr. Med. Chem
, vol.10
, pp. 1021-1034
-
-
Buss, J.L.1
Torti, F.M.2
Torti, S.V.3
-
33
-
-
79955648151
-
Gastrins, iron homeostasis and colorectal cancer
-
Kovac, S., Anderson, G. J. & Baldwin, G. S. Gastrins, iron homeostasis and colorectal cancer. Biochim. Biophys. Acta 1813, 889-895 (2011).
-
(2011)
Biochim. Biophys. Acta
, vol.1813
, pp. 1813-1889
-
-
Kovac, S.1
Anderson, G.J.2
Baldwin, G.S.3
-
34
-
-
84999700110
-
Dietary iron intake and breast cancer risk: Modulation by an antioxidant supplementation
-
Diallo, A. et al. Dietary iron intake and breast cancer risk: modulation by an antioxidant supplementation. Oncotarget 7, 79008-79016 (2016).
-
(2016)
Oncotarget
, vol.7
, pp. 79008-79016
-
-
Diallo, A.1
-
35
-
-
84892708503
-
Iron and cancer risk-a systematic review and meta-analysis of the epidemiological evidence
-
Fonseca-Nunes, A., Jakszyn, P. & Agudo, A. Iron and cancer risk-a systematic review and meta-analysis of the epidemiological evidence. Cancer Epidemiol. Biomarkers Prev 23, 12-31 (2014).
-
(2014)
Cancer Epidemiol. Biomarkers Prev
, vol.23
, pp. 12-31
-
-
Fonseca-Nunes, A.1
Jakszyn, P.2
Agudo, A.3
-
36
-
-
84924968139
-
Risk of cancer in patients with iron deficiency anemia: A nationwide population-based study
-
Hung, N. et al. Risk of cancer in patients with iron deficiency anemia: a nationwide population-based study. PLoS ONE 10, e0119647 (2015).
-
(2015)
PLoS ONE
, vol.10
, pp. e0119647
-
-
Hung, N.1
-
37
-
-
47849099083
-
Does iron have a role in breast cancer? Lancet
-
Huang, X. Does iron have a role in breast cancer? Lancet. Oncol. 9, 803-807 (2008).
-
(2008)
Oncol
, vol.9
, pp. 803-807
-
-
Huang, X.1
-
38
-
-
80155131215
-
An iron regulatory gene signature predicts outcome in breast cancer
-
Miller, L. D. et al. An iron regulatory gene signature predicts outcome in breast cancer. Cancer Res. 71, 6728-6737 (2011).
-
(2011)
Cancer Res
, vol.71
, pp. 6728-6737
-
-
Miller, L.D.1
-
39
-
-
78649673239
-
Role of ferritin alterations in human breast cancer cells
-
Shpyleva, S. I. et al. Role of ferritin alterations in human breast cancer cells. Breast Cancer Res. Treat. 126, 63-71 (2011).
-
(2011)
Breast Cancer Res. Treat
, vol.126
, pp. 63-71
-
-
Shpyleva, S.I.1
-
40
-
-
84899877769
-
Iron homeostasis and anemia markers in early breast cancer
-
Lamy, P. J., Durigova, A. & Jacot, W. Iron homeostasis and anemia markers in early breast cancer. Clin. Chim. Acta 434, 34-40 (2014).
-
(2014)
Clin. Chim. Acta
, vol.434
, pp. 34-40
-
-
Lamy, P.J.1
Durigova, A.2
Jacot, W.3
-
41
-
-
79959446383
-
TFRC and ACTB as the best reference genes to quantify Urokinase Plasminogen Activator in breast cancer
-
Majidzadeh, A. K., Esmaeili, R. & Abdoli, N. TFRC and ACTB as the best reference genes to quantify Urokinase Plasminogen Activator in breast cancer. BMC Res. Notes 4, 215 (2011).
-
(2011)
BMC Res. Notes
, vol.4
, pp. 215
-
-
Majidzadeh, A.K.1
Esmaeili, R.2
Abdoli, N.3
-
42
-
-
0028809381
-
Phase Ia trial of murine immunoglobulin A antitransferrin receptor antibody 42/6
-
Brooks, D. et al. Phase Ia trial of murine immunoglobulin A antitransferrin receptor antibody 42/6. Clin. Cancer Res. 1, 1259-1265 (1995).
-
(1995)
Clin. Cancer Res
, vol.1
, pp. 1259-1265
-
-
Brooks, D.1
-
43
-
-
77951233574
-
G9a and Glp methylate lysine 373 in the tumor suppressor p53
-
Huang, J. et al. G9a and Glp methylate lysine 373 in the tumor suppressor p53. J. Biol. Chem. 285, 9636-9641 (2010).
-
(2010)
J. Biol. Chem
, vol.285
, pp. 9636-9641
-
-
Huang, J.1
-
44
-
-
34247157226
-
Does the calcein-AM method assay the total cellular 'labile iron pool' or only a fraction of it?
-
Tenopoulou, M., Kurz, T., Doulias, P. T., Galaris, D. & Brunk, U. T. Does the calcein-AM method assay the total cellular 'labile iron pool' or only a fraction of it? Biochem. J. 403, 261-266 (2007).
-
(2007)
Biochem. J.
, vol.403
, pp. 261-266
-
-
Tenopoulou, M.1
Kurz, T.2
Doulias, P.T.3
Galaris, D.4
Brunk, U.T.5
-
45
-
-
27744522979
-
Recombinant expression and functional characterization of human hephaestin: A multicopper oxidase with ferroxidase activity
-
Griffiths, T. A., Mauk, A. G. & MacGillivray, R. T. Recombinant expression and functional characterization of human hephaestin: a multicopper oxidase with ferroxidase activity. Biochemistry 44, 14725-14731 (2005).
-
(2005)
Biochemistry
, vol.44
, pp. 14725-14731
-
-
Griffiths, T.A.1
Mauk, A.G.2
MacGillivray, R.T.3
|